Newsroom

NEW YORK--(BUSINESS WIRE)--Ladder Capital Corp (“Ladder” or the “Company”) (NYSE: LADR) today announced the declaration by its board of directors of a fourth quarter 2025 dividend of $0.23 per share of Class A common stock. The cash dividend is payable on January 15, 2026 to stockholders of record as of the close of business on December 31, 2025. About Ladder Ladder is a publicly listed, investment grade-rated commercial real estate finance company with a diversified, nationwide platform. We de...

CHICAGO--(BUSINESS WIRE)--Property Guardian, a leader in wildfire risk analytics and mitigation intelligence, today announced a strategic partnership with Allied Disaster Defense, a California-based wildfire prevention and home hardening provider. Allied will leverage Property Guardian’s parcel-level risk reports and its active wildfire monitoring platform, Property Guardian Overwatch, to scale its mitigation services and support ambitious growth plans across wildfire-exposed communities. Under...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco™ Bacto™ CD Supreme FPM Plus and Gibco™ Bacto™ CD Supreme Feed (2X), two next-generation chemically-defined formulations that expand the Gibco™ Bacto™ CD portfolio to enhance and simplify plasmid DNA and recombinant protein production using Escherichia coli (E. coli). As demand for plasmid DNA continues to surge to support expanding gene therapy and mRNA vaccin...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine secures FDA clearance for new DWI sequence, significantly expanding the Swoop® system's clinical capabilities in acute neurological care....

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company” and “Cross Country”) (Nasdaq: CCRN) today announced that John A. Martins, the Company’s President and Chief Executive Officer, has separated from the Company and ceased to serve as a member of its Board of Directors (the “Board”), effective as of December 14, 2025. The Board appointed Kevin C. Clark, the Company’s current Chairman, former Chief Executive Officer, and Co-Founder, to succeed Mr. Martins as the Compan...

SANTERAMO IN COLLE, Bari, Italy--(BUSINESS WIRE)--NATUZZI S.P.A. ANNOUNCES DATES FOR ITS 2025 THIRD QUARTER AND FIRST NINE MONTHS FINANCIAL INFORMATION AND CONFERENCE CALL...

LONDON--(BUSINESS WIRE)--Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that Craig Tooman, who has served as the Company’s President, Chief Executive Officer and Board member since 2022, agreed by mutual consent to end his employment with the Company effective 14 December 2025. Iain Ross, Chairman of the Silence Board, will lead the Company with immediate effect on an i...

NORTHBROOK, Ill.--(BUSINESS WIRE)--New research from Teletrac Navman, a leading connected mobility platform and a Vontier company, has found that 84% of fleets cite driver exoneration as a leading reason for deploying safety technology, with 53% of fleets that suffered accidents in the past 12 months successfully able to exonerate a driver. The ‘Mobilizing the Future of Fleets: 2026 Risk and Exoneration Edition’ uncovered that a third (34%) of fleets reported being impacted by fraudulent motor...

澳大利亚悉尼--(BUSINESS WIRE)--(美国商业资讯)-- 作为一家可提供全方位服务的国际知名临床合同研究组织 (CRO) 和科学咨询公司，Novotech（诺为泰）于今日发布了一份全新白皮书《早期肿瘤学——临床研究格局与CRO推动因素 (2025)》，深入剖析了塑造早期肿瘤学发展的关键驱动因素。 约60%的肿瘤学药物的临床应用能从I期推进至II期，但最终仅3-6%能获得机构监管批准。白皮书概述了影响取得早期阶段成功的关键因素，包括试验设计、受试者筛选及区域性发展路径。 白皮书指出，澳大利亚持续在全球首次人体试验（FIH）及早期临床研究领域保持重要地位。其以伦理为导向的审查框架支持在大约4至8周内启动临床试验，加之成熟的FIH中心、肿瘤学研究网络及成本效益优势，使澳大利亚成为项目后续拓展至美国、欧洲及更广阔的亚洲市场的实际启动基地。 该分析为生物技术和制药申办方提供了有关现代试验方法、基于精准治疗的策略以及全球协调执行方式如何塑造早期肿瘤学研究格局的详细分析。白皮书还强调，诺为泰凭借科学的专业知识、监管合规性以及全球5500多家临床试验中心，为这些项目提供大力支持。 重点内...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--The Marygold Companies, Inc. (NYSE American: MGLD), a global holding firm specializing in financial services, today announced that its wholly owned subsidiary, USCF Investments (USCF), has launched the USCF Oil Plus Bitcoin Strategy Fund (NYSE Arca: WTIB). This new exchange-traded fund (ETF) represents a significant milestone for USCF, marking its first venture into cryptocurrency within its extensive portfolio of alternative investment products. For furth...